title: Description of antipanic therapy in a prospective longitudinal study.
abstract: The authors present a summary scale for assessing the percentage of patients in a large longitudinal study of panic disorder who received proven effective psychopharmacologic treatment. Such a scale provides a means for assessing and comparing somatic treatments of panic disorder across medication classes. The antipanic therapy levels were applied to data on medication treatment received by 492 patients participating in a naturalistic study and reflect psychopharmacologic treatment prescribed in 11 academic centers. Results show that among patients treated by psychiatrists at major teaching hospitals only 54% of the most symptomatic groups received optimal pharmacologic treatment. Among less symptomatic patients, who nonetheless met full criteria for panic disorder with or without agoraphobia, only 43% received maximal therapy.
authors.affiliation: Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas 75235-9101, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Yonkers
authors.forename: J M
authors.initials: JM
authors.lastname: Ellison
authors.forename: D M
authors.initials: DM
authors.lastname: Shera
authors.forename: L A
authors.initials: LA
authors.lastname: Pratt
authors.forename: J O
authors.initials: JO
authors.lastname: Cole
authors.forename: E
authors.initials: E
authors.lastname: Fierman
authors.forename: M B
authors.initials: MB
authors.lastname: Keller
authors.forename: P W
authors.initials: PW
authors.lastname: Lavori
mesh_terms: D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D005260:Female; D006784:Hospitals, Teaching; D006801:Humans; D008297:Male; D008404:Massachusetts; D008875:Middle Aged; D016584:Panic Disorder / Q000188:drug therapy*; D011569:Psychiatric Status Rating Scales
chemical_list: D014151:Anti-Anxiety Agents